Logo-hpp
2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SNIP(2022):1.389
SJR(2022): 0.78
Platinum
Open Access

Health Promot Perspect. 2021;11(2): 161-170. doi: 10.34172/hpp.2021.20
PMID: 34195039        PMCID: PMC8233671

Systematic Review

Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in India: A systematic review and meta-analysis

Abhijit Dutta 1 * ORCID, Avinash Sharma 2

Cited by CrossRef: 23


1- Upadhyay M, Mahishale A, Kari A. Prevalence of premenstrual syndrome in college going girls - A cross sectional study. Clinical Epidemiology and Global Health. 2023;20:101234 [Crossref]
2- Gao M, Zhang H, Gao Z, Cheng X, Sun Y, Qiao M, Gao D. Global and regional prevalence and burden for premenstrual syndrome and premenstrual dysphoric disorder. 2022;101(1):e28528 [Crossref]
3- Liu X, Liu Z, Yang Y, Jia C. Prevalence and Associated Factors of Premenstrual Syndrome in Chinese Adolescent Girls. Child Psychiatry Hum Dev. 2023; [Crossref]
4- Gnanasekaran V, Nappinnai N, Dhinakaran S, Kalaiselvit J. MENTAL HEALTH AND MENSTRUAL HEALTH AMONG OBG POST GRADUATE STUDENTS DURING CORONA PANDEMIC TIMES. ijsr. 2022;:8 [Crossref]
5- Farkas S, Szabó A, Hegyi A, Török B, Fazekas C, Ernszt D, Kovács T, Zelena D. Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions. Biomedicines. 2022;10(4):861 [Crossref]
6- Bharathi N, E. K, Sylvia J. Premenstrual Syndrome – An Overview. IJNER. 2022;:395 [Crossref]
7- Li L, Lv X, Li Y, Zhang X, Li M, Cao Y. Development and validation of risk prediction model for premenstrual syndrome in nurses: results from the nurses-based the TARGET cohort study. Front Public Health. 2023;11 [Crossref]
8- Maity S, Wray J, Coffin T, Nath R, Nauhria S, Sah R, Waechter R, Ramdass P, Nauhria S. Academic and Social Impact of Menstrual Disturbances in Female Medical Students: A Systematic Review and Meta-Analysis. Front Med. 2022;9 [Crossref]
9- Carlini S, Lanza di Scalea T, McNally S, Lester J, Deligiannidis K. Management of Premenstrual Dysphoric Disorder: A Scoping Review. FOC. 2024;22(1):81 [Crossref]
10- Dutta A. A Guide to Cross-Sectional Studies in Homeopathic Research: Part 3 of the Research Method Series. Homœopathic Links. 2024;37(01):031 [Crossref]
11- Carlini S, Lanza di Scalea T, McNally S, Lester J, Deligiannidis K. Management of Premenstrual Dysphoric Disorder: A Scoping Review. IJWH. 2022;Volume 14:1783 [Crossref]
12- Aldossary K. Awareness and attitude towards premenstrual syndrome  among foundation year students at princess nourah university: Cross-sectional study. J Adv Pharm Educ Res. 2024;14(2):97 [Crossref]
13- Maheshwari P, Menon B, Jith A, Bhaskaran R. Prevalence of premenstrual syndrome and its effect on quality of work life in working women in South India. 2023;32(2):255 [Crossref]
14- ÇOBAN B, KARLI K. Premenstrual Sendromun İştah ve Besin Tercihi Üzerine Etkileri. 2023;2(2):19 [Crossref]
15- Zhu L, Zhou C, Li X, Liu Z, Tong Y, Yang S. Global burden and trends in female premenstrual syndrome study during 1990–2019. Arch Womens Ment Health. 2024;27(3):369 [Crossref]
16- Abrasheva M, Orlov F, Golenkov A. Premenstrual syndrome in nurses: manifestations, risk factors, treatment and prevention. Medsestra. 2024;:22 [Crossref]
17- Thakur J, Goswami M, Roy S. Do contrasting socio‐ecological conditions bring difference in premenstrual syndrome and its concomitants? A sedente‐migrant comparative study from Eastern India. American J Hum Biol. 2023;35(12) [Crossref]
18- Kwon Y, Sung D, Lee J. Association among Premenstrual Syndrome, Dietary Patterns, and Adherence to Mediterranean Diet. Nutrients. 2022;14(12):2460 [Crossref]
19- Susser L. Clinical Implications of the Neurosteroid Allopregnanolone in Reproductive Depression. Harv Rev Psychiatry. 2023;31(1):37 [Crossref]
20- Sureja V, Kheni D, Dubey V, Kansagra J, Soni Z, Bhatt S, Mathuria A, Deshpande S. Efficacy and Tolerability Evaluation of a Nutraceutical Composition Containing Vitex agnus-castus Extract (EVX40™), Pyridoxine, and Magnesium in Premenstrual Syndrome: A Real-World, Interventional, Comparative Study. 2023; [Crossref]
21- Liu X, Li R, Wang S, Zhang J. Global, regional, and national burden of premenstrual syndrome, 1990–2019: an analysis based on the Global Burden of Disease Study 2019. 2024;39(6):1303 [Crossref]
22- Reilly T, Patel S, Unachukwu I, Knox C, Wilson C, Craig M, Schmalenberger K, Eisenlohr-Moul T, Cullen A. The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis. Journal of Affective Disorders. 2024;349:534 [Crossref]
23- Çitil E, Çitil Canbay F. Premenstrual syndrome severity in Turkey: a meta-analysis study. Psychology, Health & Medicine. 2023;28(7):1783 [Crossref]
24- Eccles H, Sharma V. The association between premenstrual dysphoric disorder and depression: A systematic review. Journal of Affective Disorders Reports. 2023;12:100504 [Crossref]
25- Akın Ö, Erbil N. Investigation of coping behaviors and premenstrual syndrome among university students. Curr Psychol. 2024;43(2):1685 [Crossref]
26- SAHİN B, CURA ŞAHİN G, ŞAHİN B. The Comparison of the Premenstrual Syndrome Patients with and without COVID-19 History. 2022;6(1):65 [Crossref]
27- Andualem F, Melkam M, Takelle G, Nakie G, Tinsae T, Fentahun S, Rtbey G, Seid J, Gedef G, Bitew D, Godana T. Prevalence of premenstrual syndrome and its associated factors in Africa: a systematic review and meta-analysis. Front Psychiatry. 2024;15 [Crossref]
28- Marais-Thomas H, Chapelle F, de Vaux-Boitouzet V, Bouvet C. Trouble dysphorique prémenstruel : prises en charge médicamenteuses et psychothérapeutiques, une revue de littérature. L'Encéphale. 2024;50(2):211 [Crossref]
29- Liang X, Yang T, Liao Y, Yang Z, Lin Y, Wu X, Tao J, Gan Z. The impact of comorbid premenstrual syndrome or premenstrual dysphoric disorder on the clinical characteristics of bipolar disorder among Han Chinese women. Arch Womens Ment Health. 2024;27(1):67 [Crossref]
30- Daneshvar S, Ahmadi F, Naghizadeh M, Direckvand-Moghadam A, Mohammadian F, Jalilian M, Ghazanfari Z. Effectiveness of a school-based health education program to improve the symptoms of premenstrual syndrome in high school girls in Ilam. J Edu Health Promot. 2023;12(1):126 [Crossref]
31- Feula A, Yerrabelli D, Pal G. Effect of pranayama on sympatho-vagal imbalance and cognitive deficit in premenstrual syndrome. 2024;13(1):259 [Crossref]
32- Sharifipour F, Siahkal S, Qaderi K, Mohaghegh Z, Zahedian M, Azizi F. Effect of Curcumin on Dysmenorrhea and Symptoms of Premenstrual Syndrome: A Systematic Review and Meta-Analysis. Korean J Fam Med. 2024;45(2):96 [Crossref]
33- Phimphasone-Brady P, Page C, Ali D, Haller H, Duffy K. Racial and ethnic disparities in women’s mental health: a narrative synthesis of systematic reviews and meta-analyses of the US-based samples. Fertility and Sterility. 2023;119(3):364 [Crossref]
34- Խաչիկյան Խ, Հովհաննիսյան Հ, Քեշիշյան Ա, Հակոբյան Ա, Թոփչյան Ա. Մաշկի նախադաշտանային ախտաբանություն. 2024;:53 [Crossref]
35- Lutskaya D, Dzhibladze T, Petelin D, Sorokina O, Semin S, Volel’ B. The role of neurosteroids in the development of premenstrual dysphoric disorder. Ross vestn akush-ginekol. 2023;23(3):56 [Crossref]
36- Naik S, Nidhi Y, Kumar K, Grover S. Diagnostic validity of premenstrual dysphoric disorder: revisited. Front Glob Womens Health. 2023;4 [Crossref]
37- Zolfaghary F, Adib-Rad H, Nasiri‑Amiri F, Faramarzi M, Pasha H, gholinia-ahangar H. Effectiveness of computer-based stress inoculation training (SIT) counseling approach on anxiety, depression, and stress of students with premenstrual syndrome. BMC Public Health. 2024;24(1) [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4

  


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission